Hans Ericsson

8PUBLICATIONS
12CO-AUTHORS
Gene and molecular therapyPharmacogenomicsBiologically active moleculesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 03, 2026
The effect of mild and moderate hepatic impairment on the pharmacokinetics, safety and tolerability of balcinrenone.

|May 08, 2026
Population Pharmacokinetics of the Novel Myeloperoxidase Inhibitor Mitiperstat.

|Feb 18, 2025
The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of balcinrenone.

Chandrali S Bhattacharya, Hans Ericsson, Susanne Johansson

|Oct 14, 2024
Disposition of orally administered atuliflapon, a novel 5-lipoxygenase-activating protein inhibitor in healthy participants.

Xue-Qing Li, Bo Lindmark, Carl Amilon

|Aug 12, 2024
The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of mitiperstat.

Chandrali S Bhattacharya, Patricia Ely Pizzato, Maria Heijer

|Jun 03, 2024
A drug-drug interaction study and physiologically based pharmacokinetic modelling to assess the effect of an oral 5-lipoxygenase activating protein inhibitor on the pharmacokinetics of oral midazolam.

Jane Knöchel, Vijender Panduga, Karin Nelander

Pageof 2

Frequent Collaborators

3 joint publications

Joanna Parkinson

3 joint publications

Mikael Sunnåker

2 joint publications

Karin Nelander

2 joint publications

Jane Knöchel